Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Determinants of High Cost in Multiple Sclerosis Patients: A Claims and Chart Review Study.
MAL Is a Regulator of the Recruitment of Myelin Protein PLP to Membrane Microdomains.
All relapsing multiple sclerosis patients should be managed at a specialist clinic - Commentary.
Anti-JC virus seroprevalence in a Spanish multiple sclerosis cohort: JC virus seroprevalence in Spain.
Histopathological comparison of Kearns-Sayre syndrome and PGC-1α-deficient mice suggests a novel concept for vacuole formation in mitochondrial encephalopathy.
Analysis of MMP2-1306C/T and TIMP2G-418C polymorphisms with relapsing remitting multiple sclerosis.
Short Term Reproducibility of a High Contrast 3-D Isotropic Optic Nerve Imaging Sequence in Healthy Controls.
Integrating genome-wide association studies and gene expression data highlights dysregulated multiple sclerosis risk pathways.
Regression-Based Norms for the Brief Visuospatial Memory Test-Revised in Italian population and application in MS patients.
An Economic Evaluation of Subcutaneous and Intramuscular Interferon Beta-1a in Multiple Sclerosis Using a Direct Head-To-Head Study.
High-throughput platforms for the screening of new therapeutic targets for neurodegenerative diseases.
Validation of White-Matter Lesion Change Detection Methods on a Novel Publicly Available MRI Image Database.
Is Poor Sleep Quality Associated With Greater Disability in Patients With Multiple Sclerosis?
Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial.
Multidisciplinary rehabilitation and steroids in the management of multiple sclerosis relapses: a randomized controlled trial.
Voxel Based Morphometry in Optical Coherence Tomography: Validation & Core Findings.
A Real-World Assessment of Annual Multiple Sclerosis Prevalence and Disease-Modifying Drug Treatment Rates Using an Administrative Claims Database.
Farming, Foreign Holidays, and Vitamin D in Orkney.
ANNALS EXPRESS: Multiple Sclerosis: Assay of Free Immunoglobulin Light Chains.
Tissue damage within normal appearing white matter in early multiple sclerosis: assessment by the ratio of T1- and T2-weighted MR image intensity.
Rapidly progressive cerebellar ataxia in West Wales.
The relationship between static posturography measures and specific cognitive domains in individuals with multiple sclerosis.
MS Drugs in Development: Firategrast, Ocrelizumab, and Ofatumumab
Minimally Invasive En Bloc Resection of Massive Obstructive Atrial Tumour.
Cryopreserved vitamin D3-tolerogenic dendritic cells pulsed with autoantigens as a potential therapy for multiple sclerosis patients.
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »